Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This report describes a case of temporary hair loss due to telogen effluvium after rhytidectomy, suggesting dermatologic surgeons consider preventive measures to minimize trauma and tension on hair follicles during surgery.

In this study, most patients who underwent endoscopic brow-lift reported being satisfied with the procedure, noting improvements in appearance and confidence, with minimal and short-lived side effects.

This study found that patients with recurrent dermatophytosis experienced significant impairment in quality of life, suggesting the importance of early treatment and counseling to reduce psychosocial effects.

Adalimumab significantly improves quality of life for patients with moderate to severe hidradenitis suppurativa.

This research suggests that intraoperative unilateral occipital artery ligation can reduce the risk of complications like scalp necrosis, offering advantages such as improved visualization and reduced asymmetry during extensive scalp lift surgeries.

This case report describes the first Indian patient diagnosed with short anagen syndrome, detailing the clinical and pathological characteristics of a 30-year-old woman with the condition.

This study found that patients with alopecia areata experience reduced quality of life, particularly among women and those with severe or long-lasting disease.

This study observed that over two-thirds of women with hirsutism experienced a moderate decline in quality of life, with severity of hirsutism linked to greater impact.

This study found that premature graying significantly impacts the quality of life among affected individuals, reporting profound effects on psychological and social well-being, including guilt and mood fluctuations.

This study found that androgenic alopecia significantly impairs quality of life among adults, with higher impairment observed in males and those who are employed.

This study found that younger male patients with androgenic alopecia experienced greater stigmatization and emotional instability but maintained higher self-assuredness and better overall quality of life compared to older patients.

This study evaluated the impact of hair disorders on quality of life in Moroccan patients, finding significant impairment particularly among younger, single individuals living in rural areas, which improved noticeably after six months of treatment.

This study reported that alopecia areata significantly negatively affects quality of life, especially in female patients with long-standing or severe disease, suggesting a need for additional psychological support.

This study found that 79.2% of patients with hair disorders experienced some degree of quality of life impairment, with non-scarring types more common but scarring alopecia seeming to have a greater impact, though this observation is limited by a small sample size.

This study found a partial positive association between adulthood stressor exposure and hair cortisol levels, but noted inconsistent results across two studies, reflecting variability seen in previous research.

In a prospective observational study conducted in India, most adults with alopecia experienced quality of life impairment in the minimal-to-moderate range, with androgenetic alopecia being the most common subtype and minoxidil frequently prescribed, as reported by the researchers.

This study found that patients with androgenetic alopecia and alopecia areata experienced a significant impact on quality of life, with moderate levels of anxiety and depression, and no significant difference in psychiatric comorbidities between the groups.

This observational study found that endoscopic subcutaneous midface elevation with vertical SMAS plication safely and effectively rejuvenates the mid and lower face in patients under 45 with early facial soft-tissue ptosis, reporting no facial nerve injuries and minor complications like localized cicatricial alopecia and hematomas.

In this study, researchers found that among 7,761 patients with androgenetic alopecia, behaviors such as insufficient sleep, poor dietary habits, alcohol consumption, heavy physical labor, and specific hairstyling choices were associated with increased severity of hair loss.

This study examined the relationships between the Dermatology Life Quality Index and trichoscopic and clinical-anamnestic characteristics in young Ukrainian men with alopecia areata, finding varying strengths of mostly non-significant correlations, especially in those with grade I and III alopecia.

In this study, both alopecia areata and androgenetic alopecia were found to moderately impact quality of life, affecting emotional and social aspects in patients.

This study found that both alopecia areata and androgenetic alopecia moderately impacted patients' quality of life, affecting not only physiological but also emotional and social aspects.

In this study, patients with acute alopecia areata experienced significantly higher anxiety and depression levels, along with a worsened quality of life, compared to a control group, underscoring the importance for clinicians to address these psychiatric issues early in the condition.

This study found that patients with telogen effluvium experienced higher stress, depression, anxiety, and lower quality of life compared to healthy controls.

This study found that individuals with alopecia areata in Malaysian tertiary hospitals who are unmarried and have diabetes are more likely to experience a poorer quality of life, based on their Dermatology Life Quality Index scores.

This study found that androgenetic alopecia had a minor impact on the quality of life among individuals in a Jordanian cohort, potentially due to cultural tolerance of the condition.

In a retrospective multicenter cohort study, this research observed that baricitinib was effective and well-tolerated in treating adult patients with alopecia areata, including those with severe cases, showing promise in improving outcomes over a 12-month period with manageable side effects.

In this study, the researchers reported that baricitinib improved hair loss in a real-world setting for Japanese adults with alopecia areata, with a 64.7% success rate at 60 weeks, though prolonged episodes reduced efficacy. Common side effects were acne and mildly decreased renal function.

This study found that patients with telogen effluvium had a higher quality of life score compared to controls, despite no significant difference in self-esteem.

In this study, researchers reported that alopecia areata significantly impacts quality of life, with effects ranging from small to very large, especially for those with longer disease duration, highlighting the importance of psychological evaluation and support for affected patients.